ATE401341T1 - Vakzine enthaltend omp85 proteine von neisseria gonorrhoeae und neisseria meningitidis - Google Patents

Vakzine enthaltend omp85 proteine von neisseria gonorrhoeae und neisseria meningitidis

Info

Publication number
ATE401341T1
ATE401341T1 AT05003039T AT05003039T ATE401341T1 AT E401341 T1 ATE401341 T1 AT E401341T1 AT 05003039 T AT05003039 T AT 05003039T AT 05003039 T AT05003039 T AT 05003039T AT E401341 T1 ATE401341 T1 AT E401341T1
Authority
AT
Austria
Prior art keywords
neisseria
symptomatic
proteins
gonorrhoeae
vaccines containing
Prior art date
Application number
AT05003039T
Other languages
English (en)
Inventor
Ralph C Judd
Scott D Manning
Original Assignee
Univ Montana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Montana filed Critical Univ Montana
Priority claimed from EP98953873A external-priority patent/EP1123403A1/de
Application granted granted Critical
Publication of ATE401341T1 publication Critical patent/ATE401341T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8247Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT05003039T 1998-10-22 1998-10-22 Vakzine enthaltend omp85 proteine von neisseria gonorrhoeae und neisseria meningitidis ATE401341T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98953873A EP1123403A1 (de) 1998-10-22 1998-10-22 Omp85 proteine von neisseria gonorrhoeae uand neisseria meningitidis, zusammensetzungen die sie enthalten und verfahren zur anwendung davon
EP9822352 1998-10-22

Publications (1)

Publication Number Publication Date
ATE401341T1 true ATE401341T1 (de) 2008-08-15

Family

ID=39846647

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05003039T ATE401341T1 (de) 1998-10-22 1998-10-22 Vakzine enthaltend omp85 proteine von neisseria gonorrhoeae und neisseria meningitidis

Country Status (5)

Country Link
EP (1) EP1535928B1 (de)
AT (1) ATE401341T1 (de)
CY (1) CY1108412T1 (de)
ES (1) ES2310776T3 (de)
PT (1) PT1535928E (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69839740D1 (de) * 1998-10-22 2008-08-28 Univ Montana Vakzine enthaltend Omp85 Proteine von Neisseria gonorrhoeae und Neisseria meningitidis
US6610306B2 (en) 1998-10-22 2003-08-26 The University Of Montana OMP85 protein of neisseria meningitidis, compositions containing the same and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU22302A1 (es) * 1990-09-07 1995-01-31 Cigb Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales
JP3532563B2 (ja) * 1990-08-23 2004-05-31 ザ ユニバーシティー オブ ノースカロライナ アット チャペル ヒル Neisseria gonorrhoeaeおよびNeisseria meningitidis由来トランスフェリン結合蛋白質

Also Published As

Publication number Publication date
ES2310776T3 (es) 2009-01-16
CY1108412T1 (el) 2014-02-12
EP1535928B1 (de) 2008-07-16
EP1535928A2 (de) 2005-06-01
EP1535928A3 (de) 2005-08-17
PT1535928E (pt) 2008-10-08

Similar Documents

Publication Publication Date Title
DE60041981D1 (de) Neisseria meningitidis-serumgruppen b und c-antigene sowie ein zusätzliches antigen enthaltende zusammensetzungen
CY1117643T1 (el) Συνθεσεις νεϊσσεριακου εμβολιου που περιλαμβανουν συνδυασμο αντιγονων
BR9910089A (pt) Composições e antìgenos de neisseria meningitidis
BR9813930A (pt) antìgeno neisserial
BR9906927A (pt) Proteìnas de neisseria meningitidis
DE60045721D1 (de) Streptococcus pneumoniae Proteine und Impfstoffe
DE69630457D1 (de) Verbindungen zur immunotherapie und diagnose von tuberkulose
CY1106431T1 (el) Γονοκοκκικες πρωτεϊνες και νουκλεϊκα οξεα
MA24638A1 (fr) Vaccin
ATE120093T1 (de) Meningococcales klasse i-aussenmembranprotein- vakzin.
DK1185691T3 (da) Genomiske neisseriasekvenser og fremgangmåder til anvendelse deraf
ATE276758T1 (de) Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid
WO2001031019A3 (en) Neisserial antigenic peptides
BR0012424A (pt) Peptìdeos meningocócicos antigênicos
ATE401341T1 (de) Vakzine enthaltend omp85 proteine von neisseria gonorrhoeae und neisseria meningitidis
ATE366583T1 (de) Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407
BR0313121A (pt) Composição imunogênica, vacina, métodos de tratamento ou prevenção de doença neisserial, de preparação da composição imunogênica, de preparação da vacina, de preparação de uma imunoglobina para uso na prevenção ou tratamento de infecção neisserial, e de tratamento ou prevenção de infecção neisserial, usos da vacina e da preparação farmacêutica, cepa neisserial geneticamente engenheirada, imunoglobina, e, composição farmacêutica

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1535928

Country of ref document: EP